ID   TRI11_HUMAN             Reviewed;         468 AA.
AC   Q96F44; A6NKE2; B2RB82; B3KUS3; B4DX88; Q5VSU1; Q8NCA6; Q9C022;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2002, sequence version 2.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=E3 ubiquitin-protein ligase TRIM11;
DE            EC=2.3.2.27;
DE   AltName: Full=Protein BIA1;
DE   AltName: Full=RING finger protein 92;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM11 {ECO:0000305};
DE   AltName: Full=Tripartite motif-containing protein 11;
GN   Name=TRIM11; Synonyms=RNF92;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Piecha D., Petersohn D., Eckes B., Krieg T.;
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 97-468 (ISOFORM 3).
RC   TISSUE=Fetal brain, Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 395-468 (ISOFORM 1).
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A.,
RA   Minucci S., Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [6]
RP   INTERACTION WITH MED15, AND SUBCELLULAR LOCATION.
RX   PubMed=16904669; DOI=10.1016/j.febslet.2006.07.066;
RA   Ishikawa H., Tachikawa H., Miura Y., Takahashi N.;
RT   "TRIM11 binds to and destabilizes a key component of the activator-
RT   mediated cofactor complex (ARC105) through the ubiquitin-proteasome
RT   system.";
RL   FEBS Lett. 580:4784-4792(2006).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18248090; DOI=10.1371/journal.ppat.0040016;
RA   Uchil P.D., Quinlan B.D., Chan W.T., Luna J.M., Mothes W.;
RT   "TRIM E3 ligases interfere with early and late stages of the
RT   retroviral life cycle.";
RL   PLoS Pathog. 4:E16-E16(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that promotes the
CC       degradation of insoluble ubiquitinated proteins, including
CC       insoluble PAX6, poly-Gln repeat expanded HTT and poly-Ala repeat
CC       expanded ARX. Mediates PAX6 ubiquitination leading to proteasomal
CC       degradation, thereby modulating cortical neurogenesis. May also
CC       inhibit PAX6 transcriptional activity, possibly in part by
CC       preventing the binding of PAX6 to its consensus sequences. May
CC       contribute to the regulation of the intracellular level of HN
CC       (humanin) or HN-containing proteins through the proteasomal
CC       degradation pathway. Mediates MED15 ubiquitination leading to
CC       proteasomal degradation. May contribute to the innate restriction
CC       of retroviruses. Upon overexpression, reduces HIV-1 and murine
CC       leukemia virus infectivity, by suppressing viral gene expression.
CC       Antiviral activity depends on a functional E3 ubiquitin-protein
CC       ligase domain. May regulate TRIM5 turnover via the proteasome
CC       pathway, thus counteracting the TRIM5-mediated cross-species
CC       restriction of retroviral infection at early stages of the
CC       retroviral life cycle. {ECO:0000269|PubMed:18248090}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Binds cytoplasmic tail of integrin alpha-1. Interacts
CC       with the HN peptide (By similarity). Interacts with PHOX2B (By
CC       similarity). Interacts with PAX6 (By similarity). Interacts with
CC       MED15/ARC105; this interaction leads to MED15 ubiquitination and
CC       proteasomal degradation. {ECO:0000250,
CC       ECO:0000269|PubMed:16904669}.
CC   -!- INTERACTION:
CC       Q96RN5:MED15; NbExp=5; IntAct=EBI-851809, EBI-394506;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96F44-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96F44-2; Sequence=VSP_012057, VSP_012058;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96F44-3; Sequence=VSP_039628;
CC         Note=May be due to competing acceptor splice site. No
CC         experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The coiled-coil domain and the B30.2 domain are both
CC       necessary for interaction with HN and PAX6 (By similarity). They
CC       are also involved in MED15-binding. {ECO:0000250}.
CC   -!- DOMAIN: The B30.2 domain may be involved cellular protein quality
CC       control by promoting the degradation of insoluble ubiquitinated
CC       proteins. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH11629.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG53535.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG63300.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF327056; AAM63957.1; -; mRNA.
DR   EMBL; AK074866; BAC11254.1; -; mRNA.
DR   EMBL; AK314539; BAG37129.1; -; mRNA.
DR   EMBL; AK097825; BAG53535.1; ALT_INIT; mRNA.
DR   EMBL; AK301859; BAG63300.1; ALT_INIT; mRNA.
DR   EMBL; AL670729; CAH71671.1; -; Genomic_DNA.
DR   EMBL; AL670729; CAH71672.1; -; Genomic_DNA.
DR   EMBL; BC011629; AAH11629.1; ALT_INIT; mRNA.
DR   EMBL; BC069227; AAH69227.1; -; mRNA.
DR   EMBL; AF220125; AAG53498.1; -; mRNA.
DR   CCDS; CCDS31048.1; -. [Q96F44-1]
DR   RefSeq; NP_660215.1; NM_145214.2. [Q96F44-1]
DR   RefSeq; XP_016857901.1; XM_017002412.1. [Q96F44-3]
DR   UniGene; Hs.13543; -.
DR   ProteinModelPortal; Q96F44; -.
DR   SMR; Q96F44; -.
DR   BioGrid; 123523; 64.
DR   IntAct; Q96F44; 10.
DR   MINT; MINT-2880011; -.
DR   STRING; 9606.ENSP00000284551; -.
DR   iPTMnet; Q96F44; -.
DR   PhosphoSitePlus; Q96F44; -.
DR   BioMuta; TRIM11; -.
DR   DMDM; 26400672; -.
DR   MaxQB; Q96F44; -.
DR   PaxDb; Q96F44; -.
DR   PeptideAtlas; Q96F44; -.
DR   PRIDE; Q96F44; -.
DR   TopDownProteomics; Q96F44-1; -. [Q96F44-1]
DR   DNASU; 81559; -.
DR   Ensembl; ENST00000284551; ENSP00000284551; ENSG00000154370. [Q96F44-1]
DR   Ensembl; ENST00000366699; ENSP00000355660; ENSG00000154370. [Q96F44-2]
DR   GeneID; 81559; -.
DR   KEGG; hsa:81559; -.
DR   UCSC; uc001hss.4; human. [Q96F44-1]
DR   CTD; 81559; -.
DR   DisGeNET; 81559; -.
DR   GeneCards; MIR6742; -.
DR   GeneCards; TRIM11; -.
DR   HGNC; HGNC:16281; TRIM11.
DR   HPA; HPA028541; -.
DR   HPA; HPA043879; -.
DR   MIM; 607868; gene.
DR   neXtProt; NX_Q96F44; -.
DR   OpenTargets; ENSG00000154370; -.
DR   PharmGKB; PA38112; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   eggNOG; ENOG4111G04; LUCA.
DR   GeneTree; ENSGT00760000118893; -.
DR   HOVERGEN; HBG001357; -.
DR   InParanoid; Q96F44; -.
DR   KO; K10650; -.
DR   OMA; GDRTSWA; -.
DR   OrthoDB; EOG091G05W2; -.
DR   PhylomeDB; Q96F44; -.
DR   TreeFam; TF338674; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; Q96F44; -.
DR   UniPathway; UPA00143; -.
DR   GeneWiki; TRIM11; -.
DR   GenomeRNAi; 81559; -.
DR   PRO; PR:Q96F44; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000154370; -.
DR   CleanEx; HS_TRIM11; -.
DR   ExpressionAtlas; Q96F44; baseline and differential.
DR   Genevisible; Q96F44; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IMP:UniProtKB.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0046597; P:negative regulation of viral entry into host cell; IMP:UniProtKB.
DR   GO; GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProtKB.
DR   GO; GO:0032897; P:negative regulation of viral transcription; IDA:UniProtKB.
DR   GO; GO:0046598; P:positive regulation of viral entry into host cell; IMP:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR003879; Butyrophylin.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR006574; PRY.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF13765; PRY; 1.
DR   Pfam; PF00622; SPRY; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   PRINTS; PR01407; BUTYPHLNCDUF.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00589; PRY; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiviral defense; Coiled coil;
KW   Complete proteome; Cytoplasm; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    468       E3 ubiquitin-protein ligase TRIM11.
FT                                /FTId=PRO_0000056215.
FT   DOMAIN      268    461       B30.2/SPRY. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   ZN_FING      16     57       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING      87    128       B box-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00024}.
FT   COILED      129    208       {ECO:0000255}.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     169    169       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039628.
FT   VAR_SEQ     288    385       DVTLDPDTANPELILSEDRRSVQRGDLRQALPDSPERFDPG
FT                                PCVLGQERFTSGRHYWEVEVGDRTSWALGVCRENVNRKEKG
FT                                ELSAGNGFWILVFLGS -> RCGGPRWGDDSRRGPAKDLGS
FT                                QPRVLCPATASSKLTVSWWWVVGKTSSAHTSDISCVGIFTP
FT                                NNSSTSGNELGIQGFHSALNRIASADTTGVSTDPTD (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012057.
FT   VAR_SEQ     386    468       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012058.
FT   CONFLICT    234    234       G -> D (in Ref. 2; BAG53535).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       Q -> R (in Ref. 2; BAG37129).
FT                                {ECO:0000305}.
FT   CONFLICT    289    289       V -> M (in Ref. 2; BAG53535).
FT                                {ECO:0000305}.
FT   CONFLICT    319    319       P -> S (in Ref. 2; BAG53535).
FT                                {ECO:0000305}.
FT   CONFLICT    395    398       APLR -> GSIP (in Ref. 5; AAG53498).
FT                                {ECO:0000305}.
FT   CONFLICT    467    467       P -> A (in Ref. 5; AAG53498).
FT                                {ECO:0000305}.
SQ   SEQUENCE   468 AA;  52774 MW;  8DE4BDF79F221739 CRC64;
     MAAPDLSTNL QEEATCAICL DYFTDPVMTD CGHNFCRECI RRCWGQPEGP YACPECRELS
     PQRNLRPNRP LAKMAEMARR LHPPSPVPQG VCPAHREPLA AFCGDELRLL CAACERSGEH
     WAHRVRPLQD AAEDLKAKLE KSLEHLRKQM QDALLFQAQA DETCVLWQKM VESQRQNVLG
     EFERLRRLLA EEEQQLLQRL EEEELEVLPR LREGAAHLGQ QSAHLAELIA ELEGRCQLPA
     LGLLQDIKDA LRRVQDVKLQ PPEVVPMELR TVCRVPGLVE TLRRFRGDVT LDPDTANPEL
     ILSEDRRSVQ RGDLRQALPD SPERFDPGPC VLGQERFTSG RHYWEVEVGD RTSWALGVCR
     ENVNRKEKGE LSAGNGFWIL VFLGSYYNSS ERALAPLRDP PRRVGIFLDY EAGHLSFYSA
     TDGSLLFIFP EIPFSGTLRP LFSPLSSSPT PMTICRPKGG SGDTLAPQ
//
